Will this program interfere with my current medical treatment?

 

Q: Will this program interfere with my current medical treatment?

No. The program is designed to be used in conjunction with conventional cancer care—of your diagnosis, stage, or treatment plan. It can work for anyone and won't interfere with your current medical treatment. The program provides guidance and information about all aspects of what you will encounter on the cancer journey, and shows how to optimize your care and enhance your quality of life.

Level 3, "The Body as Garden," describes how a variety of complementary therapies can be safely integrated into your medical treatment plan and into your daily life. The program does not recommend alternative cancer therapies as a substitute for mainstream care. To be safe, it is important to discuss with your oncologist any complementary or alternative approaches that interest you.

<See All FAQs>


Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health